Reposted by Jon(athan) D
We are delighted to launch the new Causeway website!
Sign up to learn more about forthcoming announcements and clinical trials for TenoMiR®, a treatment for patients with lateral epicondylitis (tennis elbow).
Check it out here: causewaytx.com!
Sign up to learn more about forthcoming announcements and clinical trials for TenoMiR®, a treatment for patients with lateral epicondylitis (tennis elbow).
Check it out here: causewaytx.com!
Causeway Therapeutics
The Tendon Health Company: Causeway Therapeutics is developing first-in-class microRNA therapies with the potential to improve quality of life for those suffering from tendinopathy.
causewaytx.com
May 8, 2025 at 2:15 PM
We are delighted to launch the new Causeway website!
Sign up to learn more about forthcoming announcements and clinical trials for TenoMiR®, a treatment for patients with lateral epicondylitis (tennis elbow).
Check it out here: causewaytx.com!
Sign up to learn more about forthcoming announcements and clinical trials for TenoMiR®, a treatment for patients with lateral epicondylitis (tennis elbow).
Check it out here: causewaytx.com!
Reposted by Jon(athan) D
Our CEO Derek Gilchrist was recently featured in “Scrip Asks What Does 2025 Hold for Biopharma?” Check out the full article for Derek’s insights on how new approaches to microRNA delivery have the potential to target the root cause of disease: bit.ly/3FjJHvq
March 12, 2025 at 2:42 PM
Our CEO Derek Gilchrist was recently featured in “Scrip Asks What Does 2025 Hold for Biopharma?” Check out the full article for Derek’s insights on how new approaches to microRNA delivery have the potential to target the root cause of disease: bit.ly/3FjJHvq
Reposted by Jon(athan) D
#DidYouKnow that #tendinopathy impacts millions of people worldwide and costs health care systems billions of dollars per year?
Learn how Causeway is working to improve these outcomes with our #microRNA technology and lead candidate, TenoMIR, in a phase 2 trial for tennis elbow: bit.ly/4jw6ung
Learn how Causeway is working to improve these outcomes with our #microRNA technology and lead candidate, TenoMIR, in a phase 2 trial for tennis elbow: bit.ly/4jw6ung
Causeway Therapeutics
Developing miRNA therapeutics to treat common musculoskeletal diseases, such as osteoarthritis and tendinopathy, re-defining what old age looks and feels like
bit.ly
February 27, 2025 at 6:21 PM
#DidYouKnow that #tendinopathy impacts millions of people worldwide and costs health care systems billions of dollars per year?
Learn how Causeway is working to improve these outcomes with our #microRNA technology and lead candidate, TenoMIR, in a phase 2 trial for tennis elbow: bit.ly/4jw6ung
Learn how Causeway is working to improve these outcomes with our #microRNA technology and lead candidate, TenoMIR, in a phase 2 trial for tennis elbow: bit.ly/4jw6ung
Oof, interesting.. www.theguardian.com/stage/2025/j...
‘I’ve finally realised I like John Shuttleworth!’ Graham Fellows on 40 years with his organ-plonking alter ego
He has notched up tours, albums, books and a sitcom. Why is he tortured by feelings of under-achievement? As Fellows hits the road, he pops an aniseed ball and discusses his new song – about an audien...
www.theguardian.com
January 23, 2025 at 6:31 AM
Oof, interesting.. www.theguardian.com/stage/2025/j...